Ditropan and Ogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ditropan (oxybutynin chloride) and Ogen (estropipate). Common drug interactions include myalgia among females.

The phase IV clinical study analyzes what interactions people have when they take Ditropan and Ogen. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Ditropan?

Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.

What is Ogen?

Ogen has active ingredients of estropipate. eHealthMe is studying from 2,553 Ogen users. Check the latest studies of Ogen.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

18 people who take Ditropan and Ogen together, and have interactions are studied.

What are the common drug interactions of Ditropan and Ogen, by gender? *:

female:

Myalgia (muscle pain)
Accident
Chest pressure sensation (feeling of pressure on chest)
Headache (pain in head)
Abnormal behaviour
Agitation (state of anxiety or nervous excitement)
Anxiety
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
Arrhythmia (irregular heartbeat)
Arthralgia (joint pain)

male:

n/a

What are the common drug interactions of Ditropan and Ogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Aspartate aminotransferase increased
Cough
Dehydration (dryness resulting from the removal of water)
Headache (pain in head)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypochloraemia (electrolyte disturbance in which there is an abnormally low level of the chloride ion in the blood)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Hypotension (abnormally low blood pressure)
Influenza like illness
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

60+:

Hypertension (high blood pressure)
Myalgia (muscle pain)
Anxiety
Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
Arrhythmia (irregular heartbeat)
Arthralgia (joint pain)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Chest pain
Constipation
Difficulty in micturition (difficulty to urinate)

What are the existing conditions these people have? *

Joint Pain: 1 person, 5.56%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 5.56%
Growth Hormone Deficiency: 1 person, 5.56%
Empty Sella Syndrome (pituitary gland shrinks or becomes flattened): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ditropan and Ogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously